Zhitong Financial App News, Hehuang Pharmaceutical (00013.HK) announced that applications for regulatory registration of Warisha® (savolitinib) and Teresa® (osimertinib) combination therapy in Europe and Japan have been accepted.

Zhitongcaijing · 2d ago
Zhitong Financial App News, Hehuang Pharmaceutical (00013.HK) announced that applications for regulatory registration of Warisha® (savolitinib) and Teresa® (osimertinib) combination therapy in Europe and Japan have been accepted.